INDIA
COVAXIN Phase 2 and 3 Trials for 2 to 18 Age Group Approved by DCGI, Bharat Biotech To Conduct Trials on 525 Healthy Volunteers
The Drugs Controller General of India (DCGI) approves Phase II and Phase III clinical trials of COVID-19 vaccine COVAXIN in the age group of 2 to 18 years. According to a tweet by ANI, Bharat Biotech will conduct trials on 525 healthy volunteers.
The Drugs Controller General of India (DCGI) approves Phase II and Phase III clinical trials of COVID-19 vaccine COVAXIN in the age group of 2 to 18 years. According to a tweet by ANI, Bharat Biotech will conduct trials on 525 healthy volunteers.
Drugs Controller General of India (DCGI) approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 years. Bharat Biotech to conduct trials in 525 healthy volunteers pic.twitter.com/ibxAW97bAc
— ANI (@ANI) May 13, 2021
(The above story first appeared on LatestLY on May 13, 2021 10:46 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
